Genetic polymorphisms in ABCG2 and CYP1A2 are associated with imatinib dose reduction in patients treated for gastrointestinal stromal tumors

MC Verboom, Jacqueline Kloth, JJ Swen, Stefan Sleijfer, AK Reyners, N Steeghs, Ron Mathijssen, H Gelderblom, HJ Guchelaar

Research output: Contribution to journalArticleAcademicpeer-review

2 Citations (Scopus)
Original languageUndefined/Unknown
Pages (from-to)473-479
Number of pages7
JournalPharmacogenomics Journal
Volume19
Issue number5
DOIs
Publication statusPublished - 2019

Cite this